References
1) Ojasoo T, Raynaud JP. Unique steroid congeners for receptor studies. Cancer Res. 1978 Nov;38(11 Pt 2):4186-98
2) Duax WL, Griffin JF, Weeks CM, Wawrzak Z. The mechanism of action of steroid antagonists: insights from crystallographic studies. J Steroid Biochem. 1988 Oct;31(4B):481-92.
3) Mayer M, Rosen F. Interaction of anabolic steroids with glucocorticoid receptor sites in rat muscle cytosol. Am J Physiol. 1975 Nov;229(5):1381-6.
4) Donald F. Haggerty, Elaine B. Spector, Maureen Lynch, Rita Kern, Laura B. Frank, and
Stephen D. Cederbaum. Regulation by Glucocorticoids of Arginase and Argininosuccinate Synthetase in Cultured Rat Hepatoma Cells. J Biol Chem 257, (5). 2246-2253, 1982
5) Saartok T, Dahlberg E, Gustafsson JA. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin. Endocrinology. 1984 Jun;114(6):2100-6
6) Kammerer RC, Merdink JL, Jagels M, Catlin DH, Hui KK. Testing for fluoxymesterone (Halotestin) administration to man: identification of urinary metabolites by gas chromatography-mass spectrometry. J Steroid Biochem. 1990 Aug 28;36(6):659-66.
7) Nawata H, Ono K, Ohashi M, Kato K, Ibayashi H. RU486 inhibits induction of aromatase by dexamethasone via glucocorticoid receptor in cultured human skin fibroblasts. J Steroid Biochem. 1988 Jan;29(1):63-8.
8) Yang K, Khalil MW, Strutt BJ, Killinger DW. 11 beta-Hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effect on aromatase activity. J Steroid Biochem Mol Biol. 1997 Feb;60(3-4):247-53.
9) Haller J, Halasz J, Mikics E, Kruk MR. Chronic glucocorticoid deficiency-induced abnormal aggression, autonomic hypoarousal, and social deficit in rats. J Neuroendocrinol. 2004 Jun;16(6):550-7.
10) Johanna S. Schneider, Marielle K. Stone, Katherine E. Wynne-Edwards,† Teresa H. Horton, John Lydon, Bert O'Malley, Jon E. Levine. Progesterone receptors mediate male aggression toward infants. Proc Natl Acad Sci U S A. 2003 March 4; 100(5): 2951–2956.
11) Sonoko Ogawa, April E. Chester, Sylvia Curtis Hewitt, Vickie R. Walker, Jan-Ake Gustafsson, Oliver Smithies, Kenneth S. Korach, and Donald W. Pfaff. Abolition of male sexual behaviors in mice lacking estrogen receptors α and β (αβERKO). Proc Natl Acad Sci U S A. 2000 December 19; 97(26): 14737–14741.
12) Bai GZ, Hara H, Nagai K. Influence of fluoxymesterone on in vitro erythropoiesis affected by leukemic cells. Exp Hematol. 1984 Mar;12(3):171-6.
13) Schulz E, Dickmans HA, Heesen D. [Erythropoietin in serum and urine in healthy persons and patients with chronic renal disease upon hypoxic stimulation and hypoxic stimulation after pretreatment with fluoxymesterone (author's transl)]. Klin Wochenschr. 1978 Oct 15;56(20):1019-27.
14) Singer JW, Adamson JW. Steroids and hematopoiesis. II. The effect of steroids on in vitro erythroid colony growth: evidence for different target cells for different classes of steroids. J Cell Physiol. 1976 Jun;88(2):135-43.
15) Mayeux P, Billat C, Felix JM, Jacquot R. Mode of action of erythropoietin and glucocorticoids on the hepatic erythroid precursor cells: role of prostaglandins. Cell Differ. 1986 Jan;18(1):17-26.
16) Hopwood NJ, Kelch RP, Zipf WB, Hernandez RJ. The effect of synthetic androgens on the hypothalamic-pituitary-gonadal axis in boys with constitutionally delayed growth. J Pediatr. 1979 Apr;94(4):657-62.
17) Radovick S, Wondisford FE, Nakayama Y, Yamada M, Cutler GB Jr, Weintraub BD.Isolation and characterization of the human gonadotropin-releasing hormone gene in the hypothalamus and placenta.Mol Endocrinol. 1990 Mar;4(3):476-80.
18) Chandran UR, Attardi B, Friedman R, Zheng Z, Roberts JL, DeFranco DB.Glucocorticoid repression of the mouse gonadotropin-releasing hormone gene is mediated by promoter elements that are recognized by heteromeric complexes containing glucocorticoid receptor.J Biol Chem. 1996 Aug 23;271(34):20412-20.
19) Duma D, Silva-Santos JE, Assreuy J.Inhibition of glucocorticoid receptor binding by nitric oxide in endotoxemic rats.Crit Care Med. 2004 Nov;32(11):2304-10.
20) Pennisi P, D'Alcamo MA, Leonetti C, Clementi A, Cutuli VM, Riccobene S, Parisi N, Fiore CE.Supplementation of L-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model.J Bone Miner Metab. 2005;23(2):134-9.
21) Bagdade JD, Livingston R, Yee E. Effects of synthetic androgen fluoxymesterone on triglyceride secretion rates in the rat. Proc Soc Exp Biol Med. 1975 Jun;149(2):452-4.
22) Latif SA, Pardo HA, Hardy MP, Morris DJ. Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin. Mol Cell Endocrinol. 2005 Sep 23
23) Ojasoo T, Raynaud JP, Dore JC. Correspondence factor analysis of steroid libraries. Steroids. 1995 Jun;60(6):458-69.